Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201207041 Principal Investigator: Wagner-Johnston, Nina
Title: Validity of the EORTC QLQ-CIPN20 Instrument: An evaluation of the questionnaire in patients with breast cancer undergoing neoadjuvant or adjuvant chemotherapy (doxorubicin/cyclophosphamide) without known risk for development of chemotherapy-induced peripheral neuropathy (CIPN)
Phase: N/A Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to evaluate a questionnaire called the EORTC QLQ-CIPN20, which was developed to assess peripheral neuropathy caused by chemotherapy. The goal of asking you to complete this questionnaire throughout your treatment is to make sure that the questionnaire does not inadvertently indicate that patients are experiencing symptoms of peripheral neuropathy when they aren’t.
 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)